DSM-Firmenich AG

ENXTAM:DSFIR Stock Report

Market Cap: €26.0b

DSM-Firmenich Future Growth

Future criteria checks 3/6

DSM-Firmenich is forecast to grow earnings and revenue by 43.7% and 4.1% per annum respectively. EPS is expected to grow by 43.9% per annum. Return on equity is forecast to be 5.4% in 3 years.

Key information

43.7%

Earnings growth rate

43.9%

EPS growth rate

Chemicals earnings growth21.0%
Revenue growth rate4.1%
Future return on equity5.4%
Analyst coverage

Good

Last updated20 Dec 2024

Recent future growth updates

Recent updates

Estimating The Fair Value Of DSM-Firmenich AG (AMS:DSFIR)

Dec 13
Estimating The Fair Value Of DSM-Firmenich AG (AMS:DSFIR)

We Think DSM-Firmenich (AMS:DSFIR) Has A Fair Chunk Of Debt

Oct 20
We Think DSM-Firmenich (AMS:DSFIR) Has A Fair Chunk Of Debt

DSM-Firmenich AG's (AMS:DSFIR) Popularity With Investors Is Under Threat From Overpricing

Sep 23
DSM-Firmenich AG's (AMS:DSFIR) Popularity With Investors Is Under Threat From Overpricing

A Look At The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

Aug 28
A Look At The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit

Jun 20
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit

Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

May 24
Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt

Apr 27
Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt

DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 31% Below Their Intrinsic Value Estimate

Feb 18
DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 31% Below Their Intrinsic Value Estimate

DSM-Firmenich AG's (AMS:DSFIR) Share Price Could Signal Some Risk

Dec 24
DSM-Firmenich AG's (AMS:DSFIR) Share Price Could Signal Some Risk

Earnings and Revenue Growth Forecasts

ENXTAM:DSFIR - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,8349551,0941,99118
12/31/202513,3838159851,90420
12/31/202412,8184678431,70520
6/30/202412,455-1907451,452N/A
3/31/202411,541-4246591,359N/A
12/31/202310,627-6585731,265N/A
9/30/20239,686-4564341,112N/A
6/30/20238,745-254287959N/A
3/31/20238,568100301962N/A
12/31/20228,390454314965N/A
9/30/20229,5828374121,056N/A
6/30/20227,8678235101,147N/A
3/31/20227,5688226801,287N/A
12/31/20217,2698208501,427N/A
9/30/20217,9556608841,507N/A
6/30/20217,5584939061,489N/A
3/31/20217,5724239061,497N/A
12/31/20208,1064488681,494N/A
9/30/20207,9605108091,434N/A
6/30/20208,0345578101,462N/A
3/31/20209,0117228261,471N/A
12/31/20197,9986757441,385N/A
9/30/20198,2728207661,399N/A
6/30/20198,5027947471,395N/A
3/31/20199,1249346121,282N/A
12/31/20189,2671,0696981,391N/A
9/30/20189,2359846571,310N/A
6/30/20189,1062,0825501,170N/A
3/31/20188,9081,942N/A1,110N/A
12/31/20178,6321,761N/A996N/A
9/30/20178,4711,676N/A993N/A
6/30/20178,333738N/A1,028N/A
3/31/20178,166711N/A1,077N/A
12/31/20167,920645N/A1,018N/A
9/30/20167,831588N/A958N/A
6/30/20167,778274N/A914N/A
3/31/20167,749214N/A811N/A
12/31/20157,722174N/A696N/A
9/30/20157,60766N/A800N/A
6/30/20157,456114N/A820N/A
3/31/20157,245115N/A867N/A
12/31/20147,051123N/A808N/A
9/30/20147,415112N/A866N/A
6/30/20147,834138N/A885N/A
3/31/20148,362182N/A1,010N/A
12/31/20138,858252N/A998N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DSFIR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: DSFIR is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: DSFIR is expected to become profitable in the next 3 years.

Revenue vs Market: DSFIR's revenue (4.1% per year) is forecast to grow slower than the Dutch market (8.8% per year).

High Growth Revenue: DSFIR's revenue (4.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DSFIR's Return on Equity is forecast to be low in 3 years time (5.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 19:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DSM-Firmenich AG is covered by 62 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Volker BosseBaader Helvea Equity Research